Cargando…
Long-term survivors in severe aplastic anemia: standard mortality rates now comparable to controls?
Autor principal: | Bacigalupo, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690898/ https://www.ncbi.nlm.nih.gov/pubmed/37439355 http://dx.doi.org/10.3324/haematol.2023.283523 |
Ejemplares similares
-
Stem cell transplantation in aplastic anemia: Impact on choices for first line therapy
por: Bacigalupo, Andrea, et al.
Publicado: (2019) -
PB1932: GENERIC ELTHROMBOPAG WITH STANDARD IMMUNOSUPPRESSIVE THERAPY IN SEVERE APLASTIC ANEMIA
por: Ranjit Kumar, C., et al.
Publicado: (2022) -
Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation
por: Tichelli, André, et al.
Publicado: (2020) -
Severe Aplastic Anemia Presenting as Neutropenic Sepsis
por: Daniels, Natasha Faye, et al.
Publicado: (2020) -
COVID-19 in children with severe aplastic anemia
por: Thakkar, Dhwanee, et al.
Publicado: (2022)